0001601485-20-000002.txt : 20200127 0001601485-20-000002.hdr.sgml : 20200127 20200127121758 ACCESSION NUMBER: 0001601485-20-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200127 DATE AS OF CHANGE: 20200127 EFFECTIVENESS DATE: 20200127 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Angion Biomedica Corp. CENTRAL INDEX KEY: 0001601485 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113430072 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-358981 FILM NUMBER: 20548121 BUSINESS ADDRESS: STREET 1: 51 CHARLES LINDBERGH BOULEVARD CITY: UNIONDALE STATE: NY ZIP: 11553 BUSINESS PHONE: (516) 326-1200 MAIL ADDRESS: STREET 1: 51 CHARLES LINDBERGH BOULEVARD CITY: UNIONDALE STATE: NY ZIP: 11553 D 1 primary_doc.xml X0708 D LIVE 0001601485 Angion Biomedica Corp. 51 CHARLES LINDBERGH BOULEVARD UNIONDALE NY NEW YORK 11553 (516) 326-1200 DELAWARE None None Corporation true Itzhak D. Goldberg 51 Charles Lindbergh Boulevard Uniondale NY NEW YORK 11553 Executive Officer Director Chairman Jay R. Venkatesan 51 Charles Lindbergh Boulevard Uniondale NY NEW YORK 11553 Executive Officer Director Chief Executive Officer Michael Yamin 51 Charles Lindbergh Boulevard Uniondale NY NEW YORK 11553 Director Victor Ganzi 51 Charles Lindbergh Boulevard Uniondale NY NEW YORK 11553 Director Biotechnology Decline to Disclose 06b false 2020-01-14 false true true false 65000 GP Nurmenkari Inc. 153480 None None 22 Elizabeth Street SONO Square, Suite 1J Norwalk CT CONNECTICUT 06854 All States false T.R. Winston & Company, LLC 10571 None None 2049 Century Park East Suite 320 Los Angeles CA CALIFORNIA 90067 All States false 12000000 1000000 11000000 Company and Placement Agents may increase total offering amount. false 7 1200000 true 0 Assumes offering is fully subscribed. Each placement agent ("PA") will also receive warrants equal to 10% of the total amount of shares sold by such PA. 0 false Angion Biomedica Corp. /s/ Jay R. Venkatesan Jay R. Venkatesan Chief Executive Officer 2020-01-27